Biomimetic nanomedicine targeted epigenetic regulation sensitizes orthotopic bladder cancer therapy
Chinese Chemical Letters · 2026-03 · 112601
DOI: 10.1016/j.cclet.2026.112601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-03. Verfasst von Dejie Kong und 16 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Anhui Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Anhui Medical University
- National Natural Science Foundation of China
Zitieren
APA
Kong, D., Shan, G., Mei, H., Gao, S., Wang, M., Zhang, Y., Zhao, A., Liu, Y., Xia, Y., Lyu, B., Peng, W., Yin, M., Kang, L., Zhang, J., Wu, M., He, X., & Li, Y. (2026). Biomimetic nanomedicine targeted epigenetic regulation sensitizes orthotopic bladder cancer therapy. Chinese Chemical Letters, 112601. https://doi.org/10.1016/j.cclet.2026.112601
Vancouver
Kong D, Shan G, Mei H, Gao S, Wang M, Zhang Y, et al. Biomimetic nanomedicine targeted epigenetic regulation sensitizes orthotopic bladder cancer therapy. Chinese Chemical Letters. 2026:112601. doi:10.1016/j.cclet.2026.112601
BibTeX
@article{Kong2026,
author = {Kong, Dejie and Shan, Guisong and Mei, Han and Gao, Siran and Wang, Mengwen and Zhang, Yaqiang and Zhao, Ang and Liu, Yafei and Xia, Yunsong and Lyu, Bin and Peng, Weidong and Yin, Mingwei and Kang, Liping and Zhang, Jinzhi and Wu, Mingqing and He, Xiaoyan and Li, Yang},
title = {Biomimetic nanomedicine targeted epigenetic regulation sensitizes orthotopic bladder cancer therapy},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {112601},
doi = {10.1016/j.cclet.2026.112601}
}
EUVIMED